Immunohistochemical expression of π class glutathione S-transferase in the basal cell layer of benign prostate tissue following chronic treatment with finasteride

Journal of Clinical Pathology

Volumn 52, Issue 5, 1999, Pages 350-354

  Montironi, Rodolfo ^a   Mazzucchelli, Roberta ^a   Pomante, Roberto ^a   Thompson, Deborah ^b   Duval da Silva, Vinicius ^b   Vaught, Linda ^b   Bartels, Peter H ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Benign prostatic hyperplasia; Finasteride; Prostate; class glutathione S transferase

Indexed keywords

FINASTERIDE; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; BASAL CELL; BLADDER CANCER; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTECTOMY; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN EXPRESSION; TRANSURETHRAL RESECTION;

EID: 0032943495     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.5.350     Document Type: Article

References (27)

1. 1 Campbell JAH, Corrigall AV, Guy A, et al. Immunohistologic localization of alpha, mu, and pi class glutathione S-transferases in human tissues. Cancer 1991;67:1608-13.
2. 2 Canada AT, Roberson KM, Vessella RL, et al. Glutathione and glutathione S-transferase in benign and malignant prostate cell lines and prostate tissue. Biochem Pharmacol 1996;51:87-90.
3. 3 Di Ilio C, Aceto A, Bucciarelli T, et al. Glutathione transferase isoenzymes from human prostate. Biochem J 1990;271:481-5.
4. 4 Moscow JA, Fairchild CR, Madden MJ, et al. Expression of anionic glutathione-S-transferase and p-glycoprotein genes in human tissue and tumors. Cancer Res 1989,49:1422-8.
5. 5 Terrier P, Townsend AJ, Coindre JM, et al. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol 1990;137: 845-53.
6. 6 Murray GI, Taylor VE, McKey JA, et al. The immunohistochemical localization of drug-metabolizing enzymes in prostate cancer. J Pathol 1995;177:147-52.
7. 7 Ripple M, Mulcahy RT, Wilding G. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells. J Urol 1993;150:209-14.
8. 8 Toffoli G, Viel A, Tumiotto L, et al. Expression of glutathione-S-transferase-π in human tumours. Eur Cancer 1992;28:1441-6.
9. 9 Mannervik B, Awasthi YC, Board PG, et al. Nomenclature for human glutathione transferases. Biochem J 1992;282: 305-8.
10. 10 Cairns J, Wright C, Cattan AR, et al. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas. J Pathol 1992;166:19-25.
11. 11 Green JA, Robertson LJ, Clark AH. Glutathione S-transferase expression in benign and malignant ovarian tumours. Br J Cancer 1993;68:235-9.
12. 12 Hirata S, Odajima T, Kohama GI, et al. Significance of glutathione S-transferase-π as a tumor marker in patients with oral cancer. Cancer 1992;70:2381-7.
13. 13 Niitsu Y, Takahashi Y, Saito T, et al. Serum glutathione-S-transferase-π as a tumor marker for gastrointestinal malignancies. Cancer 1989;63:317-23.
14. 14 Oude Ophuis MB, Van Lieshout EMM, Roelofs HMJ, et al. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer 1998;82:936-43.
15. 15 Randall BJ, Angus B, Akiba R, et al. Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: an immunohistochemical study. Br J Cancer 1990;62:614-18.
16. 16 Shiratori Y, Soma Y, Maruyama H, et al. Immunohistochemical detection of the placental form of glutathione S-transferase in dysplastic and neoplastic human uterine cervix lesions. Cancer Res 1987;47:6806-9.
17. 17 Tew KD, Clapper ML, Greenberg RE, et al. Glutathione S-transferase in human prostate. Biochim Biophys Acta 1987;926:8-15.
18. 18 Thomas DJ, Birch PJ, Vickers J, et al. Glutathione-S-transferase expression in transitional cell carcinoma of the bladder. Br J Urol 1993;72:740-3.
19. 19 Lee WH, Morton RA, Epstein JI, et al. Cytidine methylation of regulatory sequences near the π-class glutathione S-transferase gene accompanies human prostatic carcino-genesis. Proc Natl Acad Sci USA 1994;91:11733-7.
20. 20 Cookson MS, Reuter VE, Linkov I, et al. Glutathione S-transferase pi (GST-π) class expression by immunohistochemistry in benign and malignant prostate tissue. J Urol 1997;157:673-6.
21. 21 Stoner E. 5a-Reductase inhibitors/finasteride. Prostate 1996; 6(suppl):82-7.
22. 22 Bostwick DG, Dundore PA. Biopsy of the prostate. London: Chapman and Hall, 1997.
23. 23 Brawley OW, Thompson IM. Chemoprevention of prostate cancer and the prostate cancer prevention trial. In: Schroeder FH. Recent advances in prostate cancer and benign prostatic hyperplasia. New York: Parthenon, 1997: 51-9.
24. 24 Baker AM, Oberley LW, Cohen MB. Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate 1997;32:229-33.
25. 25 Moskaluk CA, Duray PH, Cowan KH, et al. Immunohistochemical expression of π-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate. Cancer 1997;79:1595-9.
26. 26 Montironi R, Diamanti L. Morphologic changes in benign prostatic hyperplasia following chronic treatment with a 5-a-reductase inhibitor finasteride. Comparison with combination endocrine therapy. J Urol Pathol 1996;4:123-35.
27. 27 Montironi R, Valli M, Fabris G. Treatment of benign prostatic hyperplasia with a 5-a-reductase inhibitor (finasteride). Morphological evaluation in patients who failed to respond. J Clin Pathol 1996;49:324-8.